Flexible, Responsive Capital
Life Science companies utilize debt financing solutions to accelerate or broaden the scope of their clinical development, invest in new R&D or commercial infrastructures, acquire external clinical assets, extend their cash runway past important value inflection points, or shore-up their balance sheets ahead of an IPO or negotiations with strategic partners. In this vertical, Hercules Capital focuses on the following sectors:
Drug Discovery, Drug Platform, Drug Delivery, Specialty Pharma, Life Sciences Tools, Medical Devices, and more.
LIFE SCIENCES TEAM
LIFE SCIENCES TEAM
R. Bryan Jadot Senior Managing Director and Group Head - Life Sciences
Kristen Kosofsky Senior Managing Director
Janice Bourque Managing Director
Lake McGuire Managing Director
Cristy Barnes Managing Director
Michael Bowden Managing Director, Portfolio Mgmt
Mike Dutra Managing Director
Himani Bhalla Managing Director
Jeffrey Ralto Principal
Jeffrey joined Hercules in September 2021 and is a Principal in the Life Sciences Group working in the Boston office. From 2016 to 2021, Jeff was a Director and Vice President in the Healthcare Sponsor Finance group at Silicon Valley Bank where he underwrote and managed senior secured financings for private equity backed healthcare services and healthcare IT companies. Jeff was previously an Analyst and Associate at Hercules, supporting the Life Sciences and Technology groups.
Jeff graduated with honors from Northeastern University with a B.S. in Finance and is a CFA charterholder.
Featured Portfolio Companies
Hercules Capital is a strong long-term partner for TransMedics. The Hercules team took the time to work with the management team to understand the business opportunity and challenges that we faced. They have used that knowledge to strategically support the company throughout its key stages of development. They are more than a venture debt lender, they are a business partner that focuses on helping their portfolio companies succeed and grow. TransMedics and I are fortunate to be working with the Hercules team.
Waleed Hassanein, M.D. (President & CEO, TransMedics )